Find your next paid study

Indiana UniversityNCT06462521

Actual pay is set by the research site.

Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening

The investigators hypothesize that preconception and pregnancy may be a feasible and effective time to offer inherited cancer risk screening. This study will a…

Hereditary Cancer Syndrome

Columbia UniversityNCT07195071

Actual pay is set by the research site.

Supplementation of Gut-brain Axis (GLP-1)-Activating Carbohydrates for Increasing Satiety in Adolescents With Obesity

Glucagon-like peptide (GLP1) drugs have quickly become a standard treatment for the adults with obesity. These drugs target the appetite control center of the …

Obesity & Overweight

Indiana UniversityNCT07823452

~$75 – $2,000

Actual pay is set by the research site.

Phase 1

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TVB-3567 in Healthy Participants With or Without Acne and to Assess the Effect of Food in Healthy Participants

This is a 4-part study. Part A will be a randomized, double-blind, placebo-controlled investigation of single ascending doses (SAD) to assess the safety, toler…

Acne

Sagimet Biosciences Inc.NCT06989840

~$500 – $10,500

Actual pay is set by the research site.

Observational

Remote vs. In-Person Study Evaluation (RISE) Above Depression

The study will employ a randomized, parallel-group design with two-stage randomization. After an initial brief screen for basic eligibility, participants will …

Remote vs. In-PersonRemote VisitsIn-person Visits

State University of New York at BuffaloNCT07854301

Actual pay is set by the research site.

Cardiovascular Structure and Function in Mucopolysaccharidosis Types I and IVA

The purpose of this study is to better understand how heart and blood vessel problems develop in people with Mucopolysaccharidosis (MPS). The investigators are…

MPS IMPS IV AMPS - Mucopolysaccharidosis+1 more

Children's Hospital of Orange CountyNCT07361536

Actual pay is set by the research site.

B-Cell Non-Hodgkin LymphomaBurkitt LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise Specified+6 more

A Pilot Study of Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for Upfront Treatment of Aggressive B-Cell Non-Hodgkin Lymphomas

This phase II trial tests the safety, best dose, and effectiveness of epcoritamab when given with etoposide, cyclophosphamide, vincristine, doxorubicin, predni…

~$75 – $2,000

Actual pay is set by the research site.

A Randomized Phase II Study of Venetoclax and HMA-Based Therapies for the Treatment of Older and Unfit Adults With Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML): A MyeloMATCH Substudy

This phase II MyeloMATCH treatment trial compares the usual treatment of azacitidine and venetoclax to the combination treatment of azacitidine, venetoclax and…

Acute Myeloid Leukemia

National Cancer Institute (NCI)NCT06317649

~$75 – $1,800

Actual pay is set by the research site.

Phase 1

A Phase 1/2a, Multicenter, Open-Label, First in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of DB-1311 in Subjects With Advanced/Metastatic Solid Tumors

This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1311/BNT324 in subjects with advanced solid tumors.

Advanced Solid Tumors

DualityBio Inc.NCT05914116

~$150 – $4,200

Actual pay is set by the research site.

Phase 3

A Phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

A phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants with Intermediate Risk Non-Muscle Invasive Bladder Cancer …

Intermediate Risk Non-Muscle Invasive Bladder Cancer

Ferring PharmaceuticalsNCT06510374

~$50 – $2,100

Actual pay is set by the research site.

Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+2 more

A Phase II Randomized Trial of Adjuvant Therapy With Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma With High Risk Features

This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy…

National Cancer Institute (NCI)NCT04671667

~$75 – $1,800

Actual pay is set by the research site.

Observational

Cognitive Enhancement in Recurrent Depression (The COG-D-R Study)

The goal of this clinical trial is to learn if a combination of non-drug treatments works to benefit memory, thinking, and brain functioning in older individua…

AgingDepressionCognitive Symptoms